CSN (NYSE: SID) net income
CSN reported a net loss of BRL 2,002m for fiscal 2025; in fiscal 2024 it reported a net loss of BRL 2,592m. Earnings per share were −BRL 1.51.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −BRL 2,002m | — | −4.5% | −BRL 1.51 |
| 2024 | −BRL 2,592m | — | −5.9% | −BRL 1.95 |
| 2023 | −BRL 318.2m | −120.5% | −0.7% | −BRL 0.24 |
| 2022 | BRL 1,554m | −87.3% | 3.5% | BRL 1.17 |
| 2021 | BRL 12,259m | +223.1% | 25.6% | BRL 8.91 |
| 2020 | BRL 3,794m | +112.1% | 12.6% | BRL 2.75 |
| 2019 | BRL 1,789m | −64.7% | 7.0% | BRL 1.30 |
| 2018 | BRL 5,074m | +49,297.7% | 22.1% | BRL 3.69 |
| 2017 | BRL 10.3m | — | 0.1% | BRL 0.0076 |
| 2016 | −BRL 934.7m | — | −5.5% | −BRL 0.69 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the net income of CSN
- How much did CSN earn in fiscal 2025?
- CSN reported a net loss of BRL 2,002m for fiscal 2025. In fiscal 2024 it reported a net loss of BRL 2,592m.
- What are the earnings per share of CSN?
- They were −BRL 1.51 in fiscal 2025, compared with −BRL 1.95 in fiscal 2024.
- What was the most profitable year for CSN?
- Of its last 10 fiscal years, fiscal 2021, with BRL 12,259m.
- Where do the figures for CSN come from?
- From the annual report (Form 20-F) that CSN files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 20-F) that CSN files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on CSN: the CSN page · annual accounts · revenue · dividends paid.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.